A Study on the Treatment of Parkinson's Disease With Autologous Neural Stem Cells
Status:
Unknown status
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
This is a single center, single arm and open-label study to investigate the safety and
efficacy of iPS-NCS with Parkinson's Disease
Phase:
Early Phase 1
Details
Lead Sponsor:
Allife Medical Science and Technology Co., Ltd.
Collaborators:
Beijing Hospital Henan Provincial People's Hospital The First People's Hospital of Yunnan Province/First People's Hospital of Yunan Provinve New Kunhua Hospital